Therapeutic targeting of mitochondrial ROS ameliorates murine model of volume overload cardiomyopathy.
Okamura K, Nakagama Y, Takeda N, Soma K, Sato T, Isagawa T, Kido Y, Sakamoto M, Manabe I, Hirata Y, Komuro I, Ono M.
Okamura K, et al. Among authors: hirata y.
J Pharmacol Sci. 2019 Sep;141(1):56-63. doi: 10.1016/j.jphs.2019.09.005. Epub 2019 Sep 28.
J Pharmacol Sci. 2019.
PMID: 31611176
Free article.